| ●Editorial | Yamada H | 512-3 | Full text | |
| ●Symposium at the 137th Annual Meeting of the Pharmaceutical Society of Japan Partnership for NTDs drug discovery originated in Japan Organizers：Yamada H，Kita K |
515-58 | Abstract | ||
| Front line of partnership for NTDs drug discovery originated in Japan | Yamada H | 518-20 | ||
| Current status and issues of NTDs and therapeutic drugs | Kita K | 521-7 | ||
| Role of DNDi for NTDs drug development | Yamada H | 528-31 | ||
| NTD Drug Discovery Booster | Mowbray CE | 532-7 | ||
| Efforts of pharmaceutical companies for the research and development of the new therapeutic drugs to tackle life-threatening infectious diseases | Yamano Y | 538-44 | ||
| Strategies and Projects for Access to Medicine at Takeda Pharmaceutical Company Limited | Ikeura Y | 545-50 | ||
| Development and provision of medicines for neglected tropical diseases
in collaboration with external partners |
Watanabe N | 551-7 | ||
| Closing remarks | Kita K | 558 | ||
| ●Book review | ||||
| “Access: How do good health technologies get to poor people in poor countries?” | Yamada H | 559-60 | Full text | |
| ●Lecture | ||||
| Japan-Initiated Global Clinical Trials Development Project －Current status and future prospects－ | Fukushima M | 561-70 | Abstract | |
| ●Survey report | ||||
| Investigation of clinical research activity in major general hospitals in Japan | Ito K，Clinical Research and Trials Facilitation Forum | 571-608 | Abstract | |
| ●Original | ||||
| Threat of terrorism by using chemical and biological warfare agents: Bioluminescence assay as a military biodefense | Imamura O，Mwange VM | 609-15 | Full text | |
| ●The past, present and future of bioethics and research ethics (Part IV) | ||||
| How can we make the best use of clinical research results? | Tsuda S，Doi O | 617-28 | Abstract | |
| Ethics and regulations of clinical research in South Africa | Dhai A （Trans. by Kurihara C） | 629-47 | Full text | |
| International comparative study on clinical trial and human subject protection regulations －International norms, Japan, United States, South Korea, Taiwan, and South Africa－ | Kurihara C | 649-65 | Abstract | |
| ●In Memoriam: Akira Nakajima | Kurihara M | 667-8 | ||
| ●Instructions for authors［Japanese］ & ［English］ | 669-77 | Full text | ||
| ●Editor's note | Gotoh E | 679 | Full text | |
| ［Electronic publications only］ | ||||
| ●Invited lecture | ||||
| Ethics and regulations of clinical research in South Africa | Dhai A | 681-701 W15-W35 | Full text | |